Abstract. Hepatocyte growth factor activator inhibitors (HAI-1 and HAI-2) are Kunitz-type serine protease inhibitors that have a broad inhibitory spectrum against serine proteases. This study examined the role of HAI-1 and HAI-2 in uterine leiomyosarcoma (LMS) patients, and in vitro. HAI-1 and HAI-2 was examined in uterine normal smooth muscle, leiomyoma and LMS specimens using immunohistochemistry. We investigated biological functions and inhibitory effects of HAI-1 and HAI-2 using uterine LMS cell line SK-LMS-1 and SKN. The expression levels of HAI-1 and HAI-2 were significantly decreased in uterine LMS specimens relative to corresponding uterine normal smooth muscle and leiomyoma specimens. Furthermore, the low HAI-1 and HAI-2 expression was a significant predictor for poor prognosis when compared with high HAI-1 and HAI-2 expression (disease-free survival rate; p=0.024 and p=0.045, overall survival rate; p=0.043 and p=0.009). HAI-1 and HAI-2 showed potential inhibitory effects that mediated cell proliferation, migration and cellular invasion which led to apoptosis and necrosis through a reduction of HGFA, matriptase and hepsin expression. These findings indicate that HAI-1 and HAI-2 may be possible tumor suppressor genes for uterine LMS and thus, both could be considered therapeutic agents for the treatment of LMS.
Introduction
The incidence of uterine cancer throughout the world has markedly increased in recent years. This has been related, in part, to an increase in uterine sarcomas a relatively rare type, accounting for 3-5% of all uterine cancers (1, 2) . Uterine sarcomas have been classified into three main histologic subgroups, in order of decreasing incidence: carcinosarcoma, leiomyosarcoma (LMS) and endometrial stromal sarcoma. Each group of tumors is distinct with respect to pattern spread, pathological features, prognostic factors and response to treatment (3, 4) . Uterine LMS is a malignant tumor composed of cells showing distinct features of the smooth muscle lineage. Uterine LMS is graded according to a modified International Federation of Gynecology and Obstetrics (FIGO) staging system for endometrial cancer (5) . Although complete resection is frequently accomplished, the risk for recurrence after complete resection of FIGO stage I or II high grade uterine LMS is 50-80% at 2 years (6-9). The risk of recurrence is greater for patients with high stage disease, and is likely greater for tumors with higher mitotic rates, although no standard prognostic criteria have been established (3, 10) . It is now widely accepted that new approaches for the treatment of uterine LMS are pivotal to further improve the prognosis of the disease.
The malignant process involves degradation of the extracellular matrix (ECM), including the interstitial basement membranes by proteinases, which facilitates cell detachment followed by local and systemic spreading. Hepatocyte growth factor (HGF) is a multifunctional growth factor that is secreted by mesenchymal cells in the liver as an inactive single-chain pro-peptide and normally remains in this form associated with the ECM (11) . HGF is a mesenchymal-derived cytokine that acts on motility and morphogenesis in various target cells. The pleiotropic activities of HGF are mediated through its receptor, a transmembrane tyrosine kinase encoded by the pro-oncogene c-Met (12, 13) . Aberrant HGF/c-Met expressions have been implicated in human uterine LMS (14) . HGF/c-Met is secreted as an inactive pro-peptide which is cleaved by HGF activator (HGFA) into its active form. HGFA is regulated by two inhibitors, HGFA inhibitor type I (HAI-1) and type II (HAI-2), both are a type 1 transmembrane protein with NH 2 -terminal Kunitz domain (KD1) and COOH-terminal KD (KD2) in their extracellular portion (15) (16) (17) (18) . HAI-1 and HAI-2 potently inhibit a variety of enzyme serine proteases that may be involved in carcinogenesis, invasion and metastasis. HAI-1 and HAI-2 appear to be the cognate inhibitors of HGFA, matriptase, hepsin and prostasin. Among them, hepsin and matriptase belong to the type II transmembrane serine protease superfamily, whereas prostasin is a glycosylphosphatidylinositol-anchored membrane serine protease protein. Hepsin, matriptase and prostasin are potential candidates for the cellular activities of pro-hepatocyte growth factor (pro-HGF) in cancer tissues (19) (20) (21) . HAI-2 is a more efficient inhibitor of hepsin (22) , and displays a broader inhibitory spectrum than HAI-1 (16, 23) . To date, several studies on HAI-1 and HAI-2 expression in tumor tissues have been published. Previously, we reported that HAI-1 and HAI-2 levels are significantly decreased during the progression of cervical and ovarian cancer (24) (25) (26) . It has been reported that the reduced expression of HAI-1 is possibly involved in the progression of prostate, breast, and gastric cancer (27) (28) (29) . Several studies have shown that the down-regulation of HAI-2 in glioblastomas, hepatocellular and renal carcinomas was partly due to the hypermethylation of the HAI-2 promoter region (30) (31) (32) . However, it is not clear how the mechanisms of action of HAI-1 and HAI-2 are involved in uterine LMS, or how their roles are intertwined. In this study, we examined the functional role of HAI -1 and HAI-2 in uterine LMS patients and in vitro.
Patients and methods

Patients and tissues.
Patients with uterine normal smooth muscle (n=15), leiomyoma (n=15) and LMS (n=12) were treated at Okayama University Hospital between January 1996 and December 2008. Each of these patients underwent abdominal total hysterectomy at the Department of Obstetrics and Gynecology of Okayama University Hospital. Tumor specimens were obtained at the time of surgery and immediately fixed in 10% neural-buffered formalin, and embedded in paraffin. Surgical staging was reviewed based on the FIGO staging system: eight were allocated to stage I, three to stage II, and one to stage III. The disease-free survival (DFS) and overall survival (OS) rates were defined as the interval from the initial surgery to clinically proven recurrence and death, respectively. The end date of the follow-up study for conducting the analysis was 30th June 2009.
Immunohistochemical analysis and staining evaluation.
Formalin-fixed, paraffin-embedded sections, at 4 μm thick, were deparaffinized with xylene and re-hydrated in ethanol. Endogenous peroxidase activity was quenched by methanol containing 0.3% hydrogen peroxidase for 15 min. Then, the sections were incubated at room temperature with a primary antibody for HAI-1 and HAI-2 (Santa Cruz Biotechnology, Santa Cruz, CA) followed by staining using a streptavidinbiotin-peroxidase kit (Nichirei, Tokyo, Japan). The sections were counterstained with hematoxylin. The level of staining in the tumor was expressed by classifying into fourth groups by scoring the percentage of positive stained cells: 0 (negative, <10% stained cells), 1+ (weak, 10-25% stained cells), 2+ (moderate, 26-50% stained cells) and 3+ (strong, >50% stained cells). Two independent examiners with no prior knowledge of the patients' clinical data conducted the microscopic evaluations. Controversial cases were evaluated during a microscope conference. (FBS) . The SKN cell line was maintained in Ham's F12 medium with 10% FBS. Cells were grown at 37˚C in an atmosphere with 5% CO 2 in air. A cDNA encoding the whole coding region of HAI-1 or HAI-2 was constructed by polymerase chain reaction using full-length HAI-1 cDNA or HAI-2 cDNA as a template. The polymerase chain reaction products were subcloned into the EcoRI/SalI site (HAI-1) or the XbaI/SalI site (HAI-2) of the expression plasmid pCIneo (Promega, Madison, WI), as described previously (33) . The HAI-1 and HAI-2 cDNA expression vectors were transfected into each cell line using the TransFast transfection reagent (Promega). Mock transfected cells served as a control.
Western blot analysis. Cell lysates were collected and estimated using a protein assay system (Bio-Rad, Hercules, CA) according to the manufacturer's protocols. Proteins from each cell line were subjected to SDS-PAGE, and were transferred onto a nitrocellulose membrane. Polyclonal and monoclonal antibodies used for immunoblotting were as follows: HAI-1, HAI-2, and ß-actin (Sigma Chemical Co., St. Louis, MO). The working dilution of all primary antibodies was 1:1000. Membranes were then incubated with the appropriate secondary antibodies. Expressions of antigen-antibody complexes were detected with an enhanced chemiluminescence kit (Amershan Biosciences, Piscataway, NJ).
MTS assay and cell viability assay.
In order to evaluate the effects of HAI-1 and/or HAI-2 on cell proliferation, the MTS assay (Promega) was performed. Cells were seeded into 96-well plates and transfected when the cell density reached 5x10 4 cells/well. Cells were transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector for 12, 24, 36 and 48 h and then MTS was added for 1 h. The absorbance was read at a wavelength of 490 nm using an ELISA plate-reader (Bio-Rad Systems). In order to examine the cell viability after transient transfection with either HAI-1 or HAI-2, or both HAI-1 and HAI-2 in SK-LMS-1 and SKN cell lines, SYTO 10 green fluorescent nucleic acid stain and Dead red (ethidium homodimer-2) nucleic acid stain (Live/Dead ® ) reduced biohazard viability/cytotoxicity kit; Invitrogen, Eugene, OR) were added to each well and incubated for 15 min. Cell fluorescence was observed using a fluorescent microscope (Olympus, Tokyo, Japan).
Motility invasion assay.
For the evaluation of motility of SK-LMS-1 and SKN cells, a monolayer wounding (scratch) assay was performed. Cells were allowed to form a monolayer on a culture dish, and a wound was made by scratching the monolayer with a pipette tip. After the scratched cells were removed and transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector, the cells were cultivated for 12 h. The cellular motility was also estimated using Chemotaxi-cells (polycarbonate filter, pore size 8 μm; Kurabo, Osaka, Japan) coated with type IV collagen (3.6 μg per filter). Cells (1x10 5 ) in 100 μl of DMEM or Ham's F12 medium and 0.1% bovine serum albumin were placed in the upper compartment and incubated for 24 h. After incubation, the cells on the upper surface of the filter were wiped off with a cotton swab. The cells on the lower surface were stained with hematoxylin and counted in ten randomly selected fields.
Matrigel invasion assay. To investigate differences in the matrigel invasive ability between cells expressing HAI-1 and HAI-2, we used the BD BioCoat Matrigel Invasion Chamber (BD Bioscience, Bedford, MA). The SK-LMS-1 and SKN cells transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector were added in situ with 10 μg/ml of DiI (Invitrogen, Carlsbad, CA) in DMEM or Ham's F12 with 10% FBS for 1 h. Cells (5x10 4 ) of each genotype were added to inserts, and 0.75 ml of medium was added to the bottom of each well. After 48 h of incubation, membranes were removed from the insert and mounted on slides, and then invading cells were counted under the microscope. Matrigel assays were performed in triplicate.
Reverse transcription (RT)-PCR and real-time RT-PCR.
Total RNA was extracted from cell lines using the acid guanidiumphenol-chloroform method (Isogen, Nippon Gene, Tokyo, Japan) according to the manufacturer's instructions. The PCR products were analyzed using 1.5% agarose gel electrophoresis. For quantitative real-time RT-PCR using cyber green, PCR was performed in a Light Cycler (Roche Applied Science, Mannheim, Germany). As the internal control, glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was also measured using RT-PCR and real-time PCR. The primers for HAI-1, HAI-2, HGFA, matriptase, hepsin, prostasin, GAPDH, were as described previously (28, (34) (35) (36) .
FITC-conjugated Annexin V assay. In order to evaluate the effects of HAI-1 and/or HAI-2 on apoptosis and necrosis, an Annexin V-FITC reagent assay (BioVision, Mountain View, CA) was performed. Cells were seeded into 96-well plates and transfected when the cell density reached 5x10 4 cells/well. Cells were transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector for 48 h and then the cells were removed. A total of 2x10 5 cells were collected by centrifugation. Apoptosis was measured by staining with FITC-conjugated Annexin V coupled with flow cytometric analysis according to the manufacturer's recommendations.
Cell growth in monolayer, cell aggregation and soft agar.
For evaluation of cell growth in a monolayer, cells were plated at a density of 3x10 4 cells/well in 6-well plates containing DMEM or Ham's F12 with 10% FBS. The cell number was counted in triplicate after 1, 3, 5 and 7 days using hemocytometer to assess cell proliferation. To evaluate growth during cell aggregation, a cell suspension (1x10 4 cells/well) in 1 ml DMEM or Ham's F12 with 10% FBS was overlaid onto a 35-mm dish containing a 0.5%-agar base. Cells were observed under a microscope (Olympus) on day 10 after culture. To evaluate growth in soft agar, a cell suspension (1x10 4 cells/well) in 1 ml 0.2% Noble agar DMEM or Ham's F12 with 10% FBS was overlaid onto a 35-mm dish containing a 0.5%-agar base. Colonies >0.2 mm in diameter were counted on day 21 after culture. Soft agar assays were performed in triplicate.
Statistical analysis. Statistical analyses were performed using the Mann-Whitney U test for comparison with the control and One-factor ANOVA followed by Fisher's protected least significance difference test for all pair wise comparisons. The analyses were performed with the software package StatView version 5.0 (Abacus Concepts, Berkeley, CA). Differences were considered significant at p<0.05.
Results
Immunoassays. HGF-dependent activation may have a role in conventional LMS tumorigenesis, thus the pro-HGF-activation machinery might be important. However, the role of HAI-1 and HAI-2 in uterine LMS is not known. Fig. 1A1-4 illustrates the representative immunoassaying patterns of HAI-1 and HAI-2. HAI-1 and HAI-2 expression levels were significantly decreased in uterine LMS specimens relative to the corresponding uterine normal smooth muscle and leiomyoma specimens (Fig. 1B) . Furthermore, the DFS and OS curves of the 12 LMS patients according to their HAI-1 and HAI-2 expression status are shown in Fig. 1C-F , respectively. The DFS and OS rates of patients exhibiting high HAI-1 and HAI-2 expression were significantly higher than those of patients exhibiting low HAI-1 and HAI-2 expression (DFS; p=0.024 and p=0.045, OS; p=0.043 and p=0.009), respectively, Mann-Whitney U test).
The protein expression and cell proliferation. The purpose of this experiment was to examine the functional role of HAI-1 and HAI-2. A significant increase in expression of HAI-1 and HAI-2 resulted when the cells were transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector (Fig. 2A) . The cell proliferation of SK-LMS-1 and SKN cells transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector was significantly inhibited as evaluated by the MTS assay (Fig. 2B) . Cell viabilities of the SK-LMS-1 and SKN cell lines were evaluated after transient transfection with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector. The percentages of viable cells were decreased to 77.2, 72.7 and 68.1% (SK-LMS-1), and 73.0, 69.2 and 66.1% (SKN) of the control cell viabilities at 48 h after transient transfection with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector, respectively (Fig. 2C) .
Motility invasiveness and matrigel invasion assessment.
The purpose of these experiments was to study the role of uterine LMS in the motility invasiveness and matrigel invasion of cells transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector. The cells transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector were much slower as compared with the control on motility invasiveness (Fig. 3A and B) . These results suggest that HAI-1 and HAI-2 overexpression decreases cell adhesion and spreading. The percentage of cells reaching the bottom of the filter was decreased to 69.8 and 64.8%, 54.3 and 49.7%, 52.8 and 46.6% on matrigel invasion at 48 h after transient transfection with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector into SK-LMS-1 and SKN cell lines, respectively (Fig. 3C) . (Fig. 4) . Inhibition of cell growth in a monolayer, cell aggregation, and anchorage-independent cell growth in soft agar. We found a significant inhibitory effect of HAI-1 and HAI-2 on monolayer cell growth in SK-LMS-1 and SKN cells transiently transfected with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector compared to the control (Fig. 6A) . Furthermore, the transient transfection with either HAI-1 vector or HAI-2 vector, or both HAI-1 vector and HAI-2 vector into either cell line resulted in a significantly reduced number of colonies in cell aggregation tests and soft agar when compared to the control (p<0.01) (Fig. 6B and C) .
RT-PCR and real-time RT-PCR.
FITC-conjugated
Discussion
HGFA is responsible for the proteolytic activation of the precursor form of HGF in various human cancer tissues and sera (22, 28, 37) . To date, two specific inhibitors of HGFA have been identified, HAI-1 and HAI-2 are Kunitztype inhibitors that have a broad inhibitory spectrum against serine proteases. These unusual serine protease inhibitors are type I transmembrane glycoproteins that contain two extracellular Kunitz-type inhibitory domains (33) . Our previous results indicated that reduced expression of HAI-1 and HAI-2 is possibly involved in disease progression in cervical and ovarian cancers (24) (25) (26) . In the present study, we examined whether HAI-1 and HAI-2 expression were correlated with uterine normal smooth muscle, leiomyoma and LMS specimens. Szabo and colleagues have reported that studies demonstrating surface epithelium and uterine glands of the human normal uterus tract showed a high level of both HAI-1 and HAI-2 expressions (38) . The levels of HAI-1 and HAI-2 expression were significantly decreased in uterine LMS specimens relative to corresponding uterine normal smooth muscle and leiomyoma specimens. Futhermore, the low levels of HAI-1 and HAI-2 expressions were significantly associated with a poor prognosis in uterine LMS. These findings indicate that HAI-1 and HAI-2 proteins could be important tumor suppressor genes for identifying uterine LMS.
HAI-1 and HAI-2 were originally described as endogenous inhibitors of HGFA, matriptase, hepsin, and prostasin (15) (16) (17) (18) . They both have a serine proteinase domain and show enhanced expression in a variety of tumor tissues (39).
Hepsin and matriptase have been proposed to initiate signaling and proteolytic cascades through their ability to activate pro-uPA, and matriptase is known to interact with prostasin (39) (40) (41) (42) (43) . In this study, HGFA, matriptase, and hepsin were significantly inhibited by HAI-1 and HAI-2 in uterine LMS cell lines (Fig. 4A) . These membrane-bound proteases are likely to have important roles in cellular homeostasis and their dysregulated activities and expression have been implicated in tumor development and progression. To date, several studies have suggested a possible role for HAI-1 and HAI-2 in the invasion of carcinoma cells. Our previous results also showed that HAI-1 and HAI-2 inhibited cell growth and promoted apoptosis in cervical and ovarian cancers (24) (25) (26) . In breast cancer, inactivation of HAI-1 and its homologous protein HAI-2 significantly increased HGF mediated breast cancer cell migration and invasion (44) . Prostate cancer cells, after loss of HAI-1, showed an increase in invasiveness and cellular motility in vitro (45) . Engineered overexpression of HAI-1 in glioblastoma cells reduced the invasiveness in vitro (46) . In this study, we used MTS assays, cell viability, motility invasiveness assays, matrigel invasion assays, FITCconjugated Annexin V assays, and cell growth assays to examine the effects on SK-LMS-1 and SKN cells after transient transfection with either HAI-1 or HAI-2, or both HAI-1 and HAI-2. Both HAI-1 and HAI-2 significantly inhibited cell proliferation, migration and cellular invasion. Interestingly, HAI-1 and HAI-2 induced apoptosis and necrosis in SK-LMS-1 and SKN cells, as shown in Fig. 5 . Overall, HAI-1 and HAI-2 mediated cell proliferation, migration and cellular invasion which resulted in apoptosis and necrosis through a reduction of HGFA, hepsin, and matriptase expression. HAI-2 is a more efficient inhibitor than HAI-1. Furthermore, transient transfection of both HAI-1 and HAI-2 significantly reduced tumorigenesis as compared with HAI-2 alone. These findings indicate that HAI-1 and HAI-2 may be possible tumor suppressor genes of uterine LMS.
In conclusion, this study revealed a critical role for HAI-1 and HAI-2 in the disruption of uterine LMS. These findings indicate that HAI-1 and HAI-2 could be therapeutic agents for the treatment of uterine LMS. 
